Literature DB >> 3488270

Aberrancy in immunogenicity and cell-surface expression of H-2 antigens on erythrocytes.

I Nakashima, T Yoshida, T Yokochi, K Ohashi, F Nagase, K Isobe, Y Hasegawa, K Ando, R Inagi.   

Abstract

Immunogenicity for T cell-independent B-cell response assessed by splenic plaque-forming cell (PFC) response and cell-surface expression measured by laser flow cytometry of various class I H-2 antigens on mouse red blood cells (RBC) were compared. It was found that the order of magnitude of both immunogenicity and cell-surface expression on RBC is H-2Dd much greater than H-2Db greater than H-2Kd, H-2Kb. Furthermore, H-2d public antigens and H-2Ld antigens were neither immunogenic nor easily demonstrable on RBC. These findings contrasted with poor immunogenicity for PFC response (Nakashima et al. 1982, 1983) and proportionally strong expression of H-2 antigens on lymphoid cells. Immunogenicity and cell-surface expression of H-2Dd antigen on RBC were not shown to be controlled by the action of genes outside H-2D. It was therefore suggested that a number of H-2 antigens, including H-2Kd private, H-2Kb private, and H-2d public specificities are at least functionally defective on RBC. This is possibly due to the structural characteristics of the antigens. Since immunogenicity and cell-surface expression were in parallel, the expression of H-2 antigens on RBC must be dictated by a subset of B cells whose activity was assessed by PFC response. This finding supports the view that the H-2 molecules display a new category of activity which is different from their ability to activate T cells and depends on their expression on RBC.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488270     DOI: 10.1007/BF00372295

Source DB:  PubMed          Journal:  Immunogenetics        ISSN: 0093-7711            Impact factor:   2.846


  30 in total

1.  The immune response to allogeneic rat platelets; Ag-B antigens in matrix form lacking Ia.

Authors:  K I Welsh; H Burgos; J R Batchelor
Journal:  Eur J Immunol       Date:  1977-05       Impact factor: 5.532

2.  The distribution of HLA on human lymphoid, bone marrow and peripheral blood cells.

Authors:  G Brown; P Biberfeld; B Christensson; D Y Mason
Journal:  Eur J Immunol       Date:  1979-04       Impact factor: 5.532

3.  Control of primary IgM antibody responses to H-2 alloantigens by antigen-bearing live B lymphocytes.

Authors:  I Nakashima; K Mizoguchi; N Kato; F Nagase; K Isobe; M Saito; K Suzuki
Journal:  Eur J Immunol       Date:  1982-09       Impact factor: 5.532

4.  Serological detection of H-2K- and H-2D-gene products. I. Principal difference between T and B lymphocytes in expression of H-2D-encoded alloantigens.

Authors:  B Tartakovsky; P De Baetselier; S Segal
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

5.  Problems in the use of erythrocytes for RT1.A typing studies, probably due to quantitative differences in RT1.A antigen expression in different strains.

Authors:  D N Hart; J W Fabre
Journal:  Transplant Proc       Date:  1981-06       Impact factor: 1.066

6.  Mouse gene for neuraminidase activity (Neu-1) maps to the D end of H-2.

Authors:  J E Womack; C S David
Journal:  Immunogenetics       Date:  1982       Impact factor: 2.846

7.  Primary antibody response against K and D regions of the H-2a and H-2d haplotypes.

Authors:  I Malavé; H Fuji
Journal:  Transplantation       Date:  1975-12       Impact factor: 4.939

8.  Rat erythrocytes elicit antibody formation against RT1.A region-determined antigens in allogeneic recipients.

Authors:  G D Majoor; M J Van de Gaar; P J Van Breda Vriesman; E Günther
Journal:  Immunology       Date:  1981-07       Impact factor: 7.397

9.  Quantitative variation in H-2-antigen expression. I. Estimation of H-2K and H-2D expression in different strains of mice.

Authors:  H C O'Neill; I F McKenzie
Journal:  Immunogenetics       Date:  1980       Impact factor: 2.846

10.  Selective turnover and shedding of H-2K and H-2D antigens is controlled by the major histocompatibility complex. Implications for H-2-restricted recognition.

Authors:  S G Emerson; D B Murphy; R E Cone
Journal:  J Exp Med       Date:  1980-10-01       Impact factor: 14.307

View more
  1 in total

1.  Induction of high-grade anti-tumor immunity by use of a recombinant H-2Kb/avian erythroblastosis virus erbB gene transfectant.

Authors:  L N Ding; K Isobe; T Yoshida; K Kawashima; I Nakashima
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.